Evaluation of the metastatic status of lymph nodes identified using axillary reverse mapping in breast cancer patients

详细信息    查看全文

• 作者：Katsumi Ikeda (1)
  Yoshinari Ogawa (1)
  Hisateru Komatsu (2)
  Yoshihiro Mori (2)
  Akira Ishikawa (2)
  Takayoshi Nakajima (2)
  Gou Oohira (2)
  Shinya Tokunaga (3)
  Hiroko Fukushima (4)
  Takeshi Inoue (4)
  
• 关键词：Breast cancer ; Axillary reverse mapping ; Fine needle aspiration cytology ; Fluorescence image
• 刊名：World Journal of Surgical Oncology
• 出版年：2012
• 出版时间：December 2012
• 年：2012
• 卷：10
• 期：1
• 全文大小：223KB
• 参考文献：1. Giuliano AE, Hunt KK, Ballman KV, Beitsch P, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, McCall LM, Morrow M: Axillary dissection vs. no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. / JAMA 2011, 305:569-75. CrossRef
  2. Clarke M, Collins R, Darby S, Elphinstone P, Evans E, Godwin J, Gray R, Hicks C, James S, MacKinnon E, McGale P, McHugh T, Peto R, Taylor C, Wang Y, Early Breast Cancer Trialists-Collaborative Group (EBCTCG): Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trials. / Lancet 2005, 366:2087-106.
  3. Petrek JA, Haalan MC: Incidence of breast carcinoma-related lymphedema. / Cancer 1988, 83:2776-781. CrossRef
  4. Petrek JA, Senie RT, Peters M, Rosen PP: Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. / Cancer 2001, 92:1368-377. CrossRef
  5. Nesvold IL, Reinersten KV, Fossa SD, Dahl AA: The relation between arm/shoulder problem and quality of life in breast cancer survivors: a cross-sectional and longitudinal study. / J Cancer Surviv 2011, 5:62-2. CrossRef
  6. Nishio M, Ogawa Y, Ikeda K, Okutani Y, Nagahara H, Sakurai K, Tokunaga S, Hamakawa T, Nishiguchi Y, / et al.: Lymphedema following axillary lymph node dissection for breast cancer - about its etiology and risk factors. / Jpn J Breast Cancer 2007, 22:469-74.
  7. Michael S, Charikleia S, Konstantinos K: Lymphedema and breast cancer: a review of the literature. / Breast Cancer 2011, 18:174-80. CrossRef
  8. Thompson M, Korourian S, Henry-Tillman R, Adkins L, Mumford S, Westbrook KC, Klimberg VS: Axillary reverse mapping (ARM): A new concept to identify and enhance lymphatic preservation. / Ann Surg Oncol 2007, 14:1890-895. CrossRef
  9. Nos C, Leiseur B, Clough KB, Lecuru F: Blue dye injection in the arm in order to conserve the lymphatic drainage of the arm in breast cancer patients requiring an axillary dissection. / Ann Surg Oncol 2007, 14:2490-496. CrossRef
  10. Nos C, Kaufmenn G, Clough KB, Collignon MA, Zerbib E, Cusumano P, Lecuru F: Combined axillary reverse mapping (ARM) technique for breast cancer patients requiring axillary dissection. / Ann Surg Oncol 2008, 15:2550-555. CrossRef
  11. Casabona F, Bogliolo S, Menada MV, Sala P, Villa G, Ferrero S: Feasibility of axillary reverse mapping during sentinel lymph node biopsy in breast cancer. / Ann Surg Oncol 2009, 16:2459-463. CrossRef
  12. Boneti C, Korourian S, Bland K, Cox K, Adkins LL, Henry-Tillman R, Klimberg VS: Axillary reverse mapping: mapping and preserving arm Lymphatics may be important in preserving lymphedema during sentinel lymph node biopsy. / J Am Coll Surg 2008, 206:1038-042. discussion 1042-044 CrossRef
  13. Noguchi M, Yokoi M, Nakano Y: Axillary reverse mapping with indocyanine fluorescence imaging in patients with breast cancer. / J Surg Oncol 2010, 101:217-21.
  14. Bedrosian I, Babiera GV, Mittendorf EA, Kuerer HM, Pantoja L, Hunt KK, Krishnamurthy S, Meric-Bernstam F: A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients. / Cancer 2010, 116:2543-548.
  15. Noguchi M: Axillary reverse mapping for breast cancer. / Breast Cancer Res Treat 2010, 119:529-35. CrossRef
  16. Ciatto S, Brancato B, Risso G, Ambrogetti D, Bulgaresi P, Maddau C, Turco P, Houssami N: Accuracy of fine needle aspiration cytology (FNAC) of axillary lymph node as a triage test in breast staging. / Breast Cancer Res Treat 2007, 103:85-1. CrossRef
  17. Sobin L, Gospodarowicz M, Witterkind C: / TNM Classification of Malignant Tumors. 7th edition. Hoboken, NJ: Wiley; 2009:181-91.
  18. Han JW, Seo YJ, Choi JE, Kang SH, Lee SJ: The efficacy of arm node preserving surgery using axillary reverse mapping for preventing lymphedema in patients with breast cancer. / J Breast Cancer 2012, 15:91-7. CrossRef
  19. Alvarez S, Anorbe E, Alcorta P, Lopez F, Alonso I, Cortes J: Role of sonography in the diagnosis of axillary lymph node metastases in breast cancer: A systematic review. / Am J Roentgenol 2006, 186:1342-348. CrossRef
  20. Krishnamurthy S, Sneige N, Bedi DG, Edieken BS, Fornage BD, Kuerer HM, Singletary SE, Hunt KK: Role of ultrasound-guided fine needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma. / Cancer 2002, 95:982-88. CrossRef
  
• 作者单位：Katsumi Ikeda (1)
  Yoshinari Ogawa (1)
  Hisateru Komatsu (2)
  Yoshihiro Mori (2)
  Akira Ishikawa (2)
  Takayoshi Nakajima (2)
  Gou Oohira (2)
  Shinya Tokunaga (3)
  Hiroko Fukushima (4)
  Takeshi Inoue (4)
  
  1. Department of Breast Surgical Oncology, Osaka City General Hospital, 2-13-22 Miyakojima-hondori, Miyakojima-ku, Osaka, 534-0021, Japan
  2. Department of Gastroenterological Surgery, Osaka City General Hospital, Osaka, Japan
  3. Department of Clinical Oncology, Osaka City General Hospital, Osaka, Japan
  4. Department of Pathology, Osaka City General Hospital, Osaka, Japan
  

文摘

Background Axillary reverse mapping (ARM) is a new technique to preserve upper extremity lymphatic pathways during axillary lymph node dissection (ALND), thereby preventing lymphedema patients with breast cancer. However, the oncologic safety of sparing the nodes identified by ARM (ARM nodes), some of which are positive, has not been verified. We evaluated the metastatic status of ARM nodes and the efficacy of fine needle aspiration cytology (FNAC) in assessing ARM node metastasis. Methods Sixty patients with breast cancer who underwent ARM during ALND between January 2010 and July 2012 were included in this study. Twenty-five patients were clinically node-positive and underwent ALND without sentinel lymph node biopsy (SLNB). Thirty-five patients were clinically node-negative but sentinel node-positive on the SLND. The lymphatic pathway was visualized using fluorescence imaging with indocyanine green. ARM nodes in ALND field, whose status was diagnosed using FNAC, were removed and processed for histology. We evaluated the correlation between the cytological findings of FNAC and the histological analysis of excised ARM nodes. Results The mean number of ARM nodes identified per patient was 1.6 ±0.9 in both groups. In most patients without (88%) and with (79%) SLNB, the ARM nodes were located between the axillary vein and the second intercostobrachial nerve. FNAC was performed for 45 ARM nodes, 10 of which could not be diagnosed. Six of the patients without SLNB (24%) and onewith SLNB (3%) had positive ARM nodes. Of these sevenpatients, four had >3 positive ARM nodes. There was no discordance between the cytological and histological diagnosis of ARM nodes status. Conclusions Positive ARM nodes were observed in the patients not only with extensive nodal metastasis but also in those with a few positive nodes. FNAC for ARM nodes was helpful in assessing ARM nodes metastasis, which can be beneficial in sparing nodes essential for lymphatic drainage, thereby potentially reducing the incidence of lymphedema. However, the success of sampling rates needs to be improved.